Andrew Tsai Analyst PerformanceSenior Vice President at Jefferies Financial GroupAndrew Tsai is a stock analyst at Jefferies Financial Group focused in the medical sector, covering 22 publicly traded companies. Over the past year, Andrew Tsai has issued 33 stock ratings, including strong buy, buy, and hold recommendations. While full access to Andrew Tsai's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Andrew Tsai's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings37 Last 5 YearsBuy Recommendations76.47% 26 Buy RatingsCompanies Covered22 Unique Companies Ratings Distribution34RatingsDistribution of strong buy, buy, hold, and sell ratings by Andrew Tsai.RatingPercentageCount Strong Buy2.9%1 ratings Buy73.5%25 ratings Hold23.5%8 ratings Sell0.0%0 ratingsOut of 34 total stock ratings issued by Andrew Tsai at Jefferies Financial Group, the majority (73.5%) have been Buy recommendations, followed by 23.5% Hold and 2.9% Strong Buy.Best & Worst CallsBest Call000.0%AXSMApr 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%XENEMay 2020Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ90.9% of companies on NASDAQ20 companiesNYSE9.1% of companies on NYSE2 companiesAndrew Tsai, an analyst at Jefferies Financial Group, currently covers 22 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical20 companies90.9%Manufacturing1 company4.5%Computer and Technology1 company4.5%Andrew Tsai of Jefferies Financial Group specializes in stock coverage within the Medical sector, with additional focus on Manufacturing and Computer and Technology companies.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE14 companies63.6%MED - DRUGS2 companies9.1%MEDICAL SERVICES1 company4.5%BIOTECHNOLOGY1 company4.5%Miscellaneous1 company4.5%MED - GENERIC DRG1 company4.5%MED - OUTP/HM CRE1 company4.5%INTERNET SERVICES1 company4.5% Andrew Tsai's Ratings History at Jefferies Financial Group Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsCMPSCompass Pathways5/5/2026Upgrade$9.32Strong-Buy$0.0000.00% ROIAXSMAxsome Therapeutics5/4/2026Boost Price Target$228.63$275.00Buy$0.0000.00% ROICMPSCompass Pathways5/3/2026Initiated Coverage$9.01$18.00Buy$0.0000.00% ROIDRUGBright Minds Biosciences4/13/2026Initiated Coverage$83.55$145.00Buy$0.0000.00% ROIANROAlto Neuroscience3/16/2026Reiterated Rating$24.63$35.00Buy$0.0000.00% ROIXENEXenon Pharmaceuticals3/9/2026Set Price Target$62.76$100.00$0.0000.00% ROIXENEXenon Pharmaceuticals3/9/2026Reiterated Rating$61.49$65.00Buy$0.0000.00% ROIMRNAModerna3/3/2026Set Price Target$49.83$37.00Hold$0.0000.00% ROISRPTSarepta Therapeutics3/3/2026Reiterated Rating$16.14$30.00Buy$0.0000.00% ROIDNLIDenali Therapeutics3/2/2026Reiterated Rating$21.00$40.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. AXSMAxsome Therapeutics2/23/2026Set Price Target$174.72$215.00$0.0000.00% ROIAXSMAxsome Therapeutics2/3/2026Boost Price Target$185.88$245.00Buy$0.0000.00% ROIDFTXDefinium Therapeutics1/29/2026Initiated Coverage$17.24$30.00Buy$0.0000.00% ROIDFTXDefinium Therapeutics1/29/2026Initiated Coverage$16.88$30.00Buy$0.0000.00% ROIMRNAModerna1/5/2026Reiterated Rating$31.57Hold$0.0000.00% ROIVTGNVistaGen Therapeutics12/17/2025Reiterated Rating$0.85$0.90Hold$0.0000.00% ROIMRNAModerna12/12/2025Initiated Coverage$29.63$30.00Hold$0.0000.00% ROIPRAXPraxis Precision Medicines12/9/2025Reiterated Rating$262.87$450.00Buy$0.0000.00% ROIBIIBBiogen11/28/2025Boost Price Target$181.94$210.00Buy$0.0000.00% ROIMPLTMaplight Therapeutics11/21/2025Initiated Coverage$13.29$32.00Buy$0.0000.00% ROIMPLTMaplight Therapeutics11/21/2025Initiated Coverage$12.81$32.00Buy$0.0000.00% ROIANROAlto Neuroscience11/12/2025Boost Price Target$14.13$25.00Buy$0.0000.00% ROIAVDLAvadel Pharmaceuticals10/22/2025Downgrade$18.58$20.00Hold$0.0000.00% ROIPRAXPraxis Precision Medicines10/16/2025Reiterated Rating$180.72$300.00Buy$0.0000.00% ROIAKROAkero Therapeutics10/9/2025Downgrade$54.19$56.00Hold$0.0000.00% ROIBIIBBiogen9/25/2025Initiated Coverage$137.67$190.00Buy$0.0000.00% ROISRPTSarepta Therapeutics7/24/2025Lower Price Target$10.92$35.00Buy$0.0000.00% ROISTOKStoke Therapeutics7/18/2025Initiated Coverage$12.35$30.00Buy$0.0000.00% ROIBBIOBridgeBio Pharma7/14/2025Initiated Coverage$46.47$70.00Buy$0.0000.00% ROISRPTSarepta Therapeutics6/16/2025Lower Price Target$20.65$54.00Buy$0.0000.00% ROIVRNAVerona Pharma PLC American Depositary Share6/11/2025Boost Price Target$90.82$110.00Buy$0.0000.00% ROIRCKTRocket Pharmaceuticals5/28/2025Reiterated Rating$2.33Hold$0.0000.00% ROIATAIAtai Beckley5/20/2025Set Price Target$2.02$5.00$0.0000.00% ROIAXSMAxsome Therapeutics4/7/2025Initiated Coverage$98.86$200.00Buy$000.0000.00% ROIBEKEKE3/19/2025Boost Price Target$22.22$27.00Overweight$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel NicolausRaymond James FinancialBMO Capital Markets Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
